Cargando…
Apolipoprotein E Genotype e2: Neuroprotection and Its Limits
In this review, we comprehensively, qualitatively, and critically synthesized several features of APOE-e2, a known APOE protective variant, including its associations with longevity, cognition, and neuroimaging, and neuropathology, all in humans. If e2’s protective effects—and their limits—could be...
Autores principales: | Kim, Hyun, Devanand, Davangere P., Carlson, Scott, Goldberg, Terry E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329577/ https://www.ncbi.nlm.nih.gov/pubmed/35912085 http://dx.doi.org/10.3389/fnagi.2022.919712 |
Ejemplares similares
-
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
por: Risacher, Shannon L., et al.
Publicado: (2013) -
Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies
por: Goldberg, Terry E., et al.
Publicado: (2020) -
Utilizing apolipoprotein E genotypes and associated comorbidities for the assessment of the risk for dementia
por: Tung, Hsin, et al.
Publicado: (2022) -
Apolipoprotein E genotypes of normal and hyperlipidemic subjects.
por: Kim, Y. S., et al.
Publicado: (1993) -
Telmisartan and Rosuvastatin Synergistically Ameliorate Dementia and Cognitive Impairment in Older Hypertensive Patients With Apolipoprotein E Genotype
por: Hu, Wenjing, et al.
Publicado: (2020)